X4 Pharmaceuticals to Have Strong Presence at ASH 2021 with Seven Accepted Abstracts Highlighting New Clinical and Scientific Data; Company Reports Third Quarter Financial Results
Go back to X4 Pharmaceuticals to Have Strong Presence at ASH 2021 with Seven Accepted Abstracts Highlighting New Clinical and Scientific Data; Company Reports Third Quarter Financial Results| (NASDAQ: XFOR) | Delayed: 3.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.50 | 52 Week High | $ | |||
| Open | $3.50 | 52 Week Low | $ | |||
| Day High | $3.50 | P/E | N/A | |||
| Day Low | $3.50 | EPS | $ | |||
| Volume | 20 | |||||
